These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27898405)

  • 1. N-Acetyl Cysteine Attenuated the Deleterious Effects of Advanced Glycation End-Products on the Kidney of Non-Diabetic Rats.
    Thieme K; Da Silva KS; Fabre NT; Catanozi S; Monteiro MB; Santos-Bezerra DP; Costa-Pessoa JM; Oliveira-Souza M; Machado UF; Passarelli M; Correa-Giannella ML
    Cell Physiol Biochem; 2016; 40(3-4):608-620. PubMed ID: 27898405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic advanced-glycation end products treatment induces TXNIP expression and epigenetic changes in glomerular podocytes in vivo and in vitro.
    Thieme K; Pereira BMV; da Silva KS; Fabre NT; Catanozi S; Passarelli M; Correa-Giannella ML
    Life Sci; 2021 Apr; 270():118997. PubMed ID: 33453249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1.
    Machado JT; Iborra RT; Fusco FB; Castilho G; Pinto RS; Machado-Lima A; Nakandakare ER; Seguro AC; Shimizu MH; Catanozi S; Passarelli M
    Atherosclerosis; 2014 Nov; 237(1):343-52. PubMed ID: 25305669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
    Al-Hussaini H; Kilarkaje N
    Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary n-3 polyunsaturated fatty acids revert renal responses induced by a combination of 2 protocols that increase the amounts of advanced glycation end product in rats.
    de Assis AM; Rech A; Longoni A; da Silva Morrone M; de Bittencourt Pasquali MA; Perry ML; Souza DO; Moreira JC
    Nutr Res; 2015 Jun; 35(6):512-22. PubMed ID: 25963123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats.
    da Silva KS; Pinto PR; Fabre NT; Gomes DJ; Thieme K; Okuda LS; Iborra RT; Freitas VG; Shimizu MHM; Teodoro WR; Marie SKN; Woods T; Brimble MA; Pickford R; Rye KA; Okamoto M; Catanozi S; Correa-Giannela ML; Machado UF; Passarelli M
    Front Physiol; 2017; 8():723. PubMed ID: 29018354
    [No Abstract]   [Full Text] [Related]  

  • 7. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
    Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Methylglyoxal-Induced AGEs/RAGE Expression Contributes to Dermal Protection by N-Acetyl-L-Cysteine.
    Yang CT; Meng FH; Chen L; Li X; Cen LJ; Wen YH; Li CC; Zhang H
    Cell Physiol Biochem; 2017; 41(2):742-754. PubMed ID: 28214842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols.
    Garibaldi S; Barisione C; Marengo B; Ameri P; Brunelli C; Balbi M; Ghigliotti G
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28075404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of N(epsilon)-(carboxymethyl)lysine generation by the antioxidant N-acetylcysteine.
    Nakayama M; Izumi G; Nemoto Y; Shibata K; Hasegawa T; Numata M; Wang K; Kawaguchi Y; Hosoya T
    Perit Dial Int; 1999; 19(3):207-10. PubMed ID: 10433156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effect of advanced glycation end products in pancreatic islet apoptosis.
    Costal F; Oliveira E; Raposo A; Machado-Lima A; Peixoto E; Roma L; Santos L; Lopes Faria JB; Carpinelli AR; Giannella-Neto D; Passarelli M; Correa-Giannella ML
    Diabetes Metab Res Rev; 2013 May; 29(4):296-307. PubMed ID: 23315923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway.
    Uchida Y; Ohba K; Yoshioka T; Irie K; Muraki T; Maru Y
    J Biol Chem; 2004 Feb; 279(6):4075-83. PubMed ID: 14610081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy protects osteoblasts from advanced glycation end products-induced apoptosis through intracellular reactive oxygen species.
    Yang L; Meng H; Yang M
    J Mol Endocrinol; 2016 May; 56(4):291-300. PubMed ID: 26903511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
    Yuan Y; Sun H; Sun Z
    Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes.
    Odetti P; Pesce C; Traverso N; Menini S; Maineri EP; Cosso L; Valentini S; Patriarca S; Cottalasso D; Marinari UM; Pronzato MA
    Diabetes; 2003 Feb; 52(2):499-505. PubMed ID: 12540627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin.
    Furfaro AL; Menini S; Patriarca S; Pesce C; Odetti P; Cottalasso D; Marinari UM; Pronzato MA; Traverso N
    Biofactors; 2005; 24(1-4):291-8. PubMed ID: 16403990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model.
    Li X; Gao Z; Gao H; Li B; Peng T; Jiang B; Yang X; Hu Z
    Mol Med Rep; 2017 Dec; 16(6):9393-9400. PubMed ID: 29152654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury.
    Yeh WJ; Yang HY; Pai MH; Wu CH; Chen JR
    J Nutr Biochem; 2017 Jan; 39():68-76. PubMed ID: 27816762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
    Das J; Sil PC
    Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.